Profil
Peter Lipsky is the founder and Chief Medical Officer of AMPEL BioSolutions LLC, which is founded in 2013.
Postes actifs de Peter Lipsky
| Sociétés | Poste | Début |
|---|---|---|
AMPEL BioSolutions LLC
 AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Fondateur | 01/01/2013 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
AMPEL BioSolutions LLC
AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Health Technology |
